De Guzman, Keonna O.

HRN: 22-77-92  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/27/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/27/2023
04/03/2023
IV
40mg
Q24h
Potentially Septic Newborn (Thickly Msaf)
Waiting Final Action 
03/27/2023
AMPICILLIN 250MG (VIAL)
03/27/2023
04/03/2023
IV
140mg
Q12
Potentially Septic Newborn (Thickly Msaf)
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: